Clinical Trial

Reduced Nicotine Cigarettes in Smokers

Study Description

Reduced Nicotine Cigarettes in Smokers With and Without Alcohol Use Disorder

The proposed research will investigate whether smokers with vs. without current at-risk alcohol drinking (ARD) respond to reduced nicotine cigarettes by increasing their alcohol consumption or smoke exposure, thereby diminishing the hypothesized public health benefit of these new products.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - Reduced nicotine cigarettes

Participants will be assigned to undergo two experimental conditions (i.e., exclusive smoking of RNC Low or Moderate in their home environment for 7 days) in a double-blind, randomized, crossover design. The two experimental conditions will be separated by a 7-day period of return to smoking of participants' own brand of cigarette.

Additional Information

Official Study Title

Reduced Nicotine Cigarettes in Smokers With and Without Alcohol Use Disorder

Clinical Trial ID

NCT02990455

ParticipAid ID

9b6jVb